These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37 related articles for article (PubMed ID: 8349434)
1. Retinoic acid and cancer treatment. Chen MC; Hsu SL; Lin H; Yang TY Biomedicine (Taipei); 2014; 4(4):22. PubMed ID: 25520935 [TBL] [Abstract][Full Text] [Related]
3. An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92. Schiller JH; Neuberg D; Burns D; Ritch P; Larson M; Levitt M; Dutcher J Invest New Drugs; 1997; 15(4):319-24. PubMed ID: 9547674 [TBL] [Abstract][Full Text] [Related]
4. Current use and future potential role of retinoids in dermatology. Orfanos CE; Zouboulis CC; Almond-Roesler B; Geilen CC Drugs; 1997 Mar; 53(3):358-88. PubMed ID: 9074840 [TBL] [Abstract][Full Text] [Related]
5. Skin growths in the aged. Treatment considerations. Frank W; Rogers GS Drugs Aging; 1994 Mar; 4(3):194-206. PubMed ID: 8199394 [TBL] [Abstract][Full Text] [Related]
6. Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature. Piamsomboon S; Termrungruanglert W; Kudelka AP; Edwards CL; Freedman RS; Mountain CF; Delclos L; Aapro MS; DeCaro L; Bianca J; Verschraegen CF; Kavanagh JJ Anticancer Drugs; 1996 Sep; 7(7):800-4. PubMed ID: 8949994 [TBL] [Abstract][Full Text] [Related]
7. Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha. Vaishampayan U; Abrams J; Darrah D; Jones V; Mitchell MS Clin Cancer Res; 2002 Dec; 8(12):3696-701. PubMed ID: 12473578 [TBL] [Abstract][Full Text] [Related]
8. Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma. Dhingra K; Papadopoulos N; Lippman S; Lotan R; Legha SS Invest New Drugs; 1993 Feb; 11(1):39-43. PubMed ID: 8349434 [TBL] [Abstract][Full Text] [Related]
9. A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study. Sondak VK; Liu PY; Flaherty LE; Fletcher WS; Periman P; Gandara DR; Taylor SA; Balcerzak SP; Meyskens FL Cancer J Sci Am; 1999; 5(1):41-7. PubMed ID: 10188060 [TBL] [Abstract][Full Text] [Related]
10. Low activity of 13-cis-retinoic acid plus interferon alpha 2a in advanced renal cell carcinoma. Jaremtchuk AV; Aman EF; Ponce W; Zarbá JJ; Ferro AM; Alvarez R; Vigo SA Am J Clin Oncol; 2002 Apr; 25(2):123-5. PubMed ID: 11943887 [TBL] [Abstract][Full Text] [Related]
11. Combination of highly purified human leukocyte interferon alpha and 13-cis-retinoic acid for the treatment of metastatic melanoma. Fierlbeck G; Schreiner T; Rassner G Cancer Immunol Immunother; 1995 Mar; 40(3):157-64. PubMed ID: 7728774 [TBL] [Abstract][Full Text] [Related]
12. Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma. García M; del Muro XG; Tres A; Crespo C; Valladares M; López JJ; Rifà J; Pérez X; Filipovich E; Germà-Lluch JR Melanoma Res; 2006 Aug; 16(4):365-70. PubMed ID: 16845333 [TBL] [Abstract][Full Text] [Related]
13. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951). Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764 [TBL] [Abstract][Full Text] [Related]